MYLK and non-small cell lung carcinoma: A recent clinical study of patients with NSCLC found a significant positive correlation between the expression levels of myosin light chain kinase (which activates myosin II) and the likelihood of disease recurrence and metastasis (Minamiya et al, 2005), indicating that myosin IIA activation could be a factor contributing to metastasis.